Improvement of Paternal Lymphocyte Immunization to Recurrent Spontaneous Abortion of Insufficient Materno-Fetal Immuno-Recognition

李大金,余江,朱影,王明雁,孟毅

DOI: https://doi.org/10.3969/j.issn.1001-2478.2003.06.009

2003-01-01

Abstract:To compare curative impact of immunization by IFN-γ in vitro inducing paternal lymphocytes or paternal lymphocytes without in vitro treatment to recurrent spontaneous aborters of insufficient materno-fetal recognition,and to investigate therapeutic mechanisms of the immunotherapy,the 194 recurrent spontaneous abortion (RSA) patients of insufficient materno-fetal recognition were randomly divided into two groups,one group were immunized by intradermal vaccination with their paternal lymphocytes without in vitro treatment,and another group were immunized with the IFN-γ in vitro inducing paternal lymphocytes. One course of treatment was immunizing for 3 times at an interval of 3～4 weeks. The resultant pregnant outcome,blocking antibodies (BE-Ab1),anti-idiotypic antibodies to blocking antibody (BE-Ab2),and the blocking antibodies recognized by FCM were surveyed after the immunization of one treating course. The successful rate of pregnancy was 90.0% of immunization with the IFN-γ in vitro inducing paternal lymphocytes,and 84.8% of immunization with the paternal lymphocytes without in vitro treatment. It was shown by analysis of the blocking antibodies that the intradermal vaccination of paternal lymphocytes promoted elevation of BE-Ab1 and BE-Ab2 in sera of the RSA patients,immunization by the IFN-γ in vitro inducing paternal lymphocytes apparently increased level of anti-CD3 blocking antibodies in sera of the RSA patients. The intradermal vaccination of paternal lymphocytes improves pregnant outcome by way of stimulating blocking antibody production,and the immunization with the IFN-γ in vitro inducing paternal lymphocytes contributes to the further pregnant outcome by way of increasing anti-CD3 blocking antibodies.